Medical measures that influence the gastroesophageal junction.
D000464:Alginates / Q000627:therapeutic use; D000468:Alkalies / Q000627:therapeutic use; D000536:Aluminum Hydroxide / Q000627:therapeutic use; D001626:Bethanechol Compounds / Q000627:therapeutic use; D001639:Bicarbonates / Q000627:therapeutic use; D004338:Drug Combinations; D004942:Esophagitis, Peptic / Q000188:drug therapy; D004943:Esophagogastric Junction / Q000187:drug effects* / Q000503:physiopathology; D005764:Gastroesophageal Reflux / Q000188:drug therapy* / Q000503:physiopathology; D006548:Hernia, Diaphragmatic / Q000188:drug therapy*; D006551:Hernia, Hiatal / Q000188:drug therapy* / Q000503:physiopathology; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006635:Histamine H2 Antagonists / Q000627:therapeutic use; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use; D008787:Metoclopramide / Q000627:therapeutic use; D011312:Pressure; D012822:Silicon Dioxide / Q000627:therapeutic use
D000464:Alginates; D000468:Alkalies; D001626:Bethanechol Compounds; D001639:Bicarbonates; D004338:Drug Combinations; D006634:Histamine H1 Antagonists; D006635:Histamine H2 Antagonists; D000536:Aluminum Hydroxide; D012822:Silicon Dioxide; D008274:Magnesium; D008787:Metoclopramide